The price of ArcelorMittal shares is range-bound. This phase will end sooner or later when volatility comes back. Investors have an opportunity to buy the stock and target the € 29.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
In a short-term perspective, the company has interesting fundamentals.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.59 for the 2017 fiscal year.
Its low valuation, with P/E ratio at 8.76 and 9.38 for the ongoing fiscal year and 2018 respectively, makes the stock pretty attractive with regard to earnings multiples.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts covering this company mostly recommend stock overweighting or purchase.
Stock prices approach a strong long-term resistance in weekly data at EUR 25.64.
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The company's earnings releases usually do not meet expectations.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.